Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the call from Alzheimer's UK for any drugs “deemed safe and effective” to treat dementia to be made available on the NHS as soon as possible, what plans they have to do so.

To be made routinely available to National Health Service patients in England, new medicines must receive a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) and a positive recommendation from the National Institute for Health and Care Excellence (NICE) to demonstrate clinical and cost effectiveness.

Several potential new disease modifying treatments for Alzheimer’s disease are in development and MHRA, NICE, NHS England and the Department are working closely to ensure that arrangements are in place to support the adoption of any new licensed and NICE recommended treatment for Alzheimer’s disease as soon as possible.